Hedge Fund Industry News
A collection of Hedge Fund latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Bitcoin Trapped in Fragile Trading as Hedge Funds Pivot to Cash
Bitcoin settled into a narrow trading range with investors still seeking direction almost two weeks after a market collapse that wiped out the last remnants of gains registered since since Donald Trump won re-election. The downturn appears to have…
Nadeem's Macro Hedge Fund Deem Closing to New Cash at $3 Billion
Asfandyar Nadeem is closing his macro hedge fund firm to new cash, joining a raft of peers who have been shutting the doors on clients to help manage their size. His London-based Deem Global will stop taking money from new clients on March 1 as…
Europe's Wealthy Return to Hedge Funds Offering Daily Liquidity
Europe's wealthiest residents are once again pouring money into hedge fund-like products, seeking to tap the industry's standout returns after years of swelling personal fortunes. As central banks across the continent reduce benchmark interest…
Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds?
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is one of the best immunotherapy stocks to buy according to hedge funds. On February 5, Goldman Sachs lifted the price target on Iovance Biotherapeutics Inc. (NASDAQ:IOVA) to $2 from $1.50 while…
Why AstraZeneca PLC (AZN) is One of the Best Immunotherapy Stocks to Buy According to Hedge Funds
AstraZeneca PLC (NASDAQ: AZN) is one of the best immunotherapy stocks to buy according to hedge funds. AstraZeneca PLC (NASDAQ:AZN) received an update from Deutsche Bank on February 16, with the firm reiterating a Sell rating on the stock and…
Billionaire Hedge Fund Tiger Global Is Betting Big on This 1 Stock
Tiger Global Management, the New York-based billionaire investor Chase Coleman-led hedge fund and venture powerhouse, is making headlines again with an aggressive pivot into the newly public Wealthfront Corporation (WLTH), signaling strong…
Famous Hedge Fund Duquesne Is Buying Up This 1 Big Bank Stock. Should You?
Goldman Sachs (GS) stock has been in a steady uptrend with returns of 38% in the last 52 weeks. This rally has been supported by healthy quarterly results, with Goldman dominating the dealmaking market in 2025. As a matter of fact, the investment…
MA Financial's tech caution pays off as AI rattles private markets
MA Financial says its aversion to lending to technology companies has paid off at a time when other private asset managers that are more heavily exposed have been punished from fears of artificial intelligence disruption. The ASX-listed company…
Strong Earnings Growth Lifted Novanta (NOVT) in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across all major indices, yet underlying conditions…
Digi International (DGII) Benefited from Faster Than Expected Recurring Services Revenue
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across all major indices, yet underlying conditions…
BNP Plans to Expand Miami Office Following 47% Revenue Growth
BNP Paribas SA, which opened a Miami office in late 2023, is expanding headcount and holding internal discussions to add more business lines as its bet on serving the hedge fund community and other institutional investors locally pays off. After…
2 stats show how US markets may be losing their edge over international competition
Global markets' pecking order could be shifting. That's the fear being voiced by more investors in recent months as doubts swirl around American exceptionalism — the idea that investors can expect better returns on US assets relative to…
Palantir's stock has dropped a third from its peak. Michael Burry has a new line of attack.
With Palantir Technologies' stock now down nearly a third from its peak, Michael Burry has a new line of attack against the AI-services company. Burry, the former hedge-fund manager chronicled in “The Big Short” for his bets against…
Where is Pfizer Inc. (PFE) Headed?
Pfizer Inc. (NYSE: PFE) is one of the best immunotherapy stocks to buy according to hedge funds. On February 12, Daiwa downgraded Pfizer Inc. (NYSE:PFE) to Neutral from Outperform and set a $27 price target. In another development, Pfizer Inc.
Where is Novartis AG (NVS) Headed?
Novartis AG (NYSE: NVS) is one of the best immunotherapy stocks to buy according to hedge funds. Novartis AG (NYSE:NVS) announced on February 13 final results from the Phase III ALIGN study, stating that Vanrafia (atrasentan) showed a positive…
Receive a Daily briefing on Hedge Fund Industry News
Get Started